Gabapentin Completed Phase 2 Trials for Sickle Cell Disease (SCD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01954927Pain Management in Children and Young Adults With Sickle Cell Disease